Modulation of μ-mediated antinociception by δ agonists: characterization with antagonists

Julius S. Heyman, Qi Jiang, Richard B. Rothman, Henry I. Mosberg, Frank Porreca

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

The functional interactions between supraspinal μ and δ receptors were characterized in the mouse using μ receptor-selective antagonists. The effects of pretreatment with the μ opioid antagonists, β-funaltrexamine (β-FNA) and naloxonazine on the modulation of morphine antinociception by the δ agonists [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Ala2, Met5]enkephalinamide (DAMA) were studied. When co-administered in the same i.c.v. injection, a sub-antinociceptive dose of DPDPE consistently and significantly increased the antinociceptive potency of morphine in control animals, while a sub-effective dose of DAMA decreased morphine antinociception; both the respective increase and the decrease of morphine potency by DPDPE and DAMA had been previously shown to be blocked by ICI 174,864, a δ antagonist. Pretreatment of mice with the non-equilibrium μ antagonist β-FNA 4 h prior to testing, a pretreatment which had no effect on i.c.v. DPDPE or DAMA antinociception, prevented the modulation of morphine antinociception by both DPDPE and DAMA. Pretreatment with the long acting μ1 antagonist naloxonazine, 24 h prior to testing, failed to affect the modulation of morphine antinociception by either DPDPE or DAMA; such a pretreatment had no effect on the antinociceptive effects of DPDPE or DAMA when given alone. These results provide further support for the concept of a functionally coupled μ-δ receptor complex which is sensitive to antagonism by β-FNA, but not naloxonazine, and support the notion that subtypes of opioid μ and δ (i.e. complexed and non-complexed) receptors may exist.

Original languageEnglish (US)
Pages (from-to)43-52
Number of pages10
JournalEuropean Journal of Pharmacology
Volume169
Issue number1
DOIs
StatePublished - Oct 4 1989

Fingerprint

D-Penicillamine (2,5)-Enkephalin
Morphine
Narcotic Antagonists
Opioid Analgesics

Keywords

  • (Intracerebroventricular, Mouse)
  • Naloxonazine
  • Opioid antinociception
  • β-Funaltrexamine (β-FNA)
  • δ Opioid receptors
  • μ Opioid receptors

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Modulation of μ-mediated antinociception by δ agonists : characterization with antagonists. / Heyman, Julius S.; Jiang, Qi; Rothman, Richard B.; Mosberg, Henry I.; Porreca, Frank.

In: European Journal of Pharmacology, Vol. 169, No. 1, 04.10.1989, p. 43-52.

Research output: Contribution to journalArticle

Heyman, Julius S. ; Jiang, Qi ; Rothman, Richard B. ; Mosberg, Henry I. ; Porreca, Frank. / Modulation of μ-mediated antinociception by δ agonists : characterization with antagonists. In: European Journal of Pharmacology. 1989 ; Vol. 169, No. 1. pp. 43-52.
@article{f94e5f4aa9a44d1595b7f7f069bbd7ed,
title = "Modulation of μ-mediated antinociception by δ agonists: characterization with antagonists",
abstract = "The functional interactions between supraspinal μ and δ receptors were characterized in the mouse using μ receptor-selective antagonists. The effects of pretreatment with the μ opioid antagonists, β-funaltrexamine (β-FNA) and naloxonazine on the modulation of morphine antinociception by the δ agonists [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Ala2, Met5]enkephalinamide (DAMA) were studied. When co-administered in the same i.c.v. injection, a sub-antinociceptive dose of DPDPE consistently and significantly increased the antinociceptive potency of morphine in control animals, while a sub-effective dose of DAMA decreased morphine antinociception; both the respective increase and the decrease of morphine potency by DPDPE and DAMA had been previously shown to be blocked by ICI 174,864, a δ antagonist. Pretreatment of mice with the non-equilibrium μ antagonist β-FNA 4 h prior to testing, a pretreatment which had no effect on i.c.v. DPDPE or DAMA antinociception, prevented the modulation of morphine antinociception by both DPDPE and DAMA. Pretreatment with the long acting μ1 antagonist naloxonazine, 24 h prior to testing, failed to affect the modulation of morphine antinociception by either DPDPE or DAMA; such a pretreatment had no effect on the antinociceptive effects of DPDPE or DAMA when given alone. These results provide further support for the concept of a functionally coupled μ-δ receptor complex which is sensitive to antagonism by β-FNA, but not naloxonazine, and support the notion that subtypes of opioid μ and δ (i.e. complexed and non-complexed) receptors may exist.",
keywords = "(Intracerebroventricular, Mouse), Naloxonazine, Opioid antinociception, β-Funaltrexamine (β-FNA), δ Opioid receptors, μ Opioid receptors",
author = "Heyman, {Julius S.} and Qi Jiang and Rothman, {Richard B.} and Mosberg, {Henry I.} and Frank Porreca",
year = "1989",
month = "10",
day = "4",
doi = "10.1016/0014-2999(89)90815-7",
language = "English (US)",
volume = "169",
pages = "43--52",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Modulation of μ-mediated antinociception by δ agonists

T2 - characterization with antagonists

AU - Heyman, Julius S.

AU - Jiang, Qi

AU - Rothman, Richard B.

AU - Mosberg, Henry I.

AU - Porreca, Frank

PY - 1989/10/4

Y1 - 1989/10/4

N2 - The functional interactions between supraspinal μ and δ receptors were characterized in the mouse using μ receptor-selective antagonists. The effects of pretreatment with the μ opioid antagonists, β-funaltrexamine (β-FNA) and naloxonazine on the modulation of morphine antinociception by the δ agonists [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Ala2, Met5]enkephalinamide (DAMA) were studied. When co-administered in the same i.c.v. injection, a sub-antinociceptive dose of DPDPE consistently and significantly increased the antinociceptive potency of morphine in control animals, while a sub-effective dose of DAMA decreased morphine antinociception; both the respective increase and the decrease of morphine potency by DPDPE and DAMA had been previously shown to be blocked by ICI 174,864, a δ antagonist. Pretreatment of mice with the non-equilibrium μ antagonist β-FNA 4 h prior to testing, a pretreatment which had no effect on i.c.v. DPDPE or DAMA antinociception, prevented the modulation of morphine antinociception by both DPDPE and DAMA. Pretreatment with the long acting μ1 antagonist naloxonazine, 24 h prior to testing, failed to affect the modulation of morphine antinociception by either DPDPE or DAMA; such a pretreatment had no effect on the antinociceptive effects of DPDPE or DAMA when given alone. These results provide further support for the concept of a functionally coupled μ-δ receptor complex which is sensitive to antagonism by β-FNA, but not naloxonazine, and support the notion that subtypes of opioid μ and δ (i.e. complexed and non-complexed) receptors may exist.

AB - The functional interactions between supraspinal μ and δ receptors were characterized in the mouse using μ receptor-selective antagonists. The effects of pretreatment with the μ opioid antagonists, β-funaltrexamine (β-FNA) and naloxonazine on the modulation of morphine antinociception by the δ agonists [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Ala2, Met5]enkephalinamide (DAMA) were studied. When co-administered in the same i.c.v. injection, a sub-antinociceptive dose of DPDPE consistently and significantly increased the antinociceptive potency of morphine in control animals, while a sub-effective dose of DAMA decreased morphine antinociception; both the respective increase and the decrease of morphine potency by DPDPE and DAMA had been previously shown to be blocked by ICI 174,864, a δ antagonist. Pretreatment of mice with the non-equilibrium μ antagonist β-FNA 4 h prior to testing, a pretreatment which had no effect on i.c.v. DPDPE or DAMA antinociception, prevented the modulation of morphine antinociception by both DPDPE and DAMA. Pretreatment with the long acting μ1 antagonist naloxonazine, 24 h prior to testing, failed to affect the modulation of morphine antinociception by either DPDPE or DAMA; such a pretreatment had no effect on the antinociceptive effects of DPDPE or DAMA when given alone. These results provide further support for the concept of a functionally coupled μ-δ receptor complex which is sensitive to antagonism by β-FNA, but not naloxonazine, and support the notion that subtypes of opioid μ and δ (i.e. complexed and non-complexed) receptors may exist.

KW - (Intracerebroventricular, Mouse)

KW - Naloxonazine

KW - Opioid antinociception

KW - β-Funaltrexamine (β-FNA)

KW - δ Opioid receptors

KW - μ Opioid receptors

UR - http://www.scopus.com/inward/record.url?scp=0024317489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024317489&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(89)90815-7

DO - 10.1016/0014-2999(89)90815-7

M3 - Article

C2 - 2557223

AN - SCOPUS:0024317489

VL - 169

SP - 43

EP - 52

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -